Valuation: Sartorius AG

Market Cap 14.77B 17.1B 13.88B 12.62B 23.73B 1,635B 24.12B 163B 63.59B 819B 64.21B 62.81B 2,721B P/E 2026 *
62.3x
P/E 2027 * 48.3x
Enterprise Value 18.34B 21.24B 17.24B 15.68B 29.48B 2,031B 29.96B 202B 78.97B 1,017B 79.75B 78.01B 3,380B EV / Sales 2026 *
4.93x
EV / Sales 2027 * 4.42x
Free-Float
35.87%
Yield 2026 *
0.34%
Yield 2027 * 0.41%
1 day+2.53%
1 week+9.32%
Current month+15.03%
1 month+2.04%
3 months+16.24%
6 months+5.86%
Current year-0.27%
1 week 53.94
Extreme 53.94
57.97
1 month 48.34
Extreme 48.34
57.97
Current year 46.97
Extreme 46.97
62.15
1 year 43.72
Extreme 43.72
62.15
3 years 38.24
Extreme 38.235
83.59
5 years 38.24
Extreme 38.235
128.99
10 years 38.24
Extreme 38.235
128.99
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2025
Director of Finance/CFO 55 01/04/2024
Chief Operating Officer 70 01/01/2001
Director TitleAgeSince
Director/Board Member 62 01/09/2002
Chairman 69 19/07/2017
Director/Board Member 77 29/11/2011
Change 5-day change 1-year change 3-year change Capi.($)
+2.53%+9.32% - - 17.03B
+1.02%+2.28%+20.56%-35.06% 17.03B
-2.98%+4.48%-7.86%+94.13% 1.82B
-5.17%+15.51%-45.32%-81.41% 1.03B
-0.44%-2.23%-27.52%+19.28% 985M
-0.05%+49.11%+71.66%-10.52% 780M
+0.95%+5.03%-36.88%-50.09% 690M
+3.92%+21.65%-39.26%-41.27% 622M
-0.54%+14.53%+43.85%+43.44% 418M
+5.89%+6.05%-40.58%-38.02% 417M
Average +0.40%+9.81%-6.82%-11.06% 2.64B
Weighted average by Cap. +1.27%+4.14%+11.32%-23.43%

Financials

2026 *2027 *
Net sales 3.72B 4.31B 3.5B 3.18B 5.98B 412B 6.08B 41B 16.03B 206B 16.19B 15.84B 686B 4.08B 4.73B 3.84B 3.49B 6.56B 452B 6.67B 44.96B 17.58B 226B 17.75B 17.37B 752B
Net income 256M 296M 240M 218M 411M 28.3B 417M 2.81B 1.1B 14.17B 1.11B 1.09B 47.09B 328M 380M 308M 280M 527M 36.33B 536M 3.61B 1.41B 18.19B 1.43B 1.4B 60.45B
Net Debt 3.57B 4.14B 3.36B 3.05B 5.74B 396B 5.84B 39.35B 15.39B 198B 15.54B 15.2B 659B 3.27B 3.78B 3.07B 2.79B 5.25B 362B 5.34B 35.99B 14.07B 181B 14.21B 13.9B 602B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
13/08/26 $54.98 +0.92% 1,534
12/08/26 $54.48 -1.04% 2,555
11/08/26 $55.05 -0.17% 3,341
10/08/26 $55.15 +1.50% 10,094
07/08/26 $54.33 +2.55% 5,855
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
235.10EUR
Average target price
265.95EUR
Spread / Average Target
+13.12%

Quarterly revenue - Rate of surprise